ID
45593
Description
Principal Investigator: Lisa Boardman, MD, Mayo Clinic, Rochester, MN, USA MeSH: Colorectal Neoplasms,Adenoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001384 In the US, CRC incidence has declined with uptake in colonoscopy for early detection and removal of polyps, the precursor lesion, can stop a cancer from developing but in spite of this, CRC remains the second leading cause of cancer death in the United States. One third of people who undergo screening colonoscopy will have adenomatous polyps, but less than 5% of the time are these polyps presumed to go on to develop into cancer. Why does one polyp develop into cancer while another one that looks very similar does not. In this proposal we will identify what molecular genetic changes in the genome, in the mRNA expression and genetic methylation patterns will distinguish a polyp that has already transformed into cancer from one that has not.
Link
Keywords
Versions (1)
- 2/6/23 2/6/23 - Simon Heim
Copyright Holder
Lisa Boardman, MD, Mayo Clinic, Rochester, MN, USA
Uploaded on
February 6, 2023
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs001384 Time Lapse to Cancer-Defining the Transition from Polyp to Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject source, and affection status for polyp to cancer.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use and sample source.
- This subject phenotype table includes subjects' age, sex, and race.
- This sample attributes table includes body site where sample was collected, analyte type, histological type, tumor status, tumor stage, and sequencing center.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject source, and affection status for polyp to cancer.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use and sample source.
- This subject phenotype table includes subjects' age, sex, and race.
- This sample attributes table includes body site where sample was collected, analyte type, histological type, tumor status, tumor stage, and sequencing center.
C0680251 (UMLS CUI [1,2])
C0685938 (UMLS CUI [1,2])
C0032584 (UMLS CUI [1,3])
C0021390 (UMLS CUI [1,4])
C0543467 (UMLS CUI [1,5])
C0014245 (UMLS CUI [1,6])
C0205210 (UMLS CUI [1,7])
C0332147 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,3])
C0685938 (UMLS CUI [1,4])
C0032584 (UMLS CUI [1,5])
C0241889 (UMLS CUI [1,6])
C0024623 (UMLS CUI [1,7])
C0153425 (UMLS CUI [1,8])
C0238198 (UMLS CUI [1,9])
C0009402 (UMLS CUI [1,10])
C0021390 (UMLS CUI [1,11])
C0014245 (UMLS CUI [1,12])
C0014245 (UMLS CUI [1,2])
C4723751 (UMLS CUI [1,3])
C0685938 (UMLS CUI [1,4])
C0032584 (UMLS CUI [1,5])
C0205539 (UMLS CUI [1,6])
C0749059 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
C0021430 (UMLS CUI [1,2])
C0033167 (UMLS CUI [1,2])